Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens

Area of Science:

• Biochemistry
• Molecular Biology
• Parasitology

Background:

• Trypanosomatid pathogens (Trypanosoma brucei, Trypanosoma cruzi, Leishmania spp.) cause significant human and animal diseases.
• Drug development against these pathogens is challenging.
• Mitochondrial RNA editing, performed by editosomes, is a unique target for anti-parasitic therapies.

Purpose of the Study:

• To review methods for discovering RNA editing inhibitors.
• To discuss recently identified inhibitors of the Trypanosoma brucei editosome.
• To explore the potential of these inhibitors in studying RNA editing and developing new drugs.

Main Methods:

• Review of literature on RNA editing inhibitor discovery.
• Discussion of virtual and high-throughput screening methods.
• Analysis of identified inhibitors against the T. brucei editosome.

Main Results:

• Recent creative screening methods have yielded novel inhibitors targeting the T. brucei editosome.
• These inhibitors can block or perturb specific steps in RNA editing.
• The inhibitors show potential for studying editosome dynamics and function.

Conclusions:

• RNA editing inhibitors represent a promising avenue for anti-trypanosomatid drug development.
• Further understanding of inhibitor mechanisms is crucial for therapeutic applications.
• These compounds can serve as valuable tools for fundamental research into RNA editing.